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Summary of: van Wetering CR, Hoogendoorn M, Mol SM, 
Rutten-van Mölken MP, Schols AM (2009) Short- and long-
term efficacy of a community-based COPD management 
program in less advanced COPD: a randomized controlled 
trial. Thorax Early online: DOI: 10.1136/thx.2009.118620. 
[Prepared by Mark Elkins, CAP Co-ordinator.]
Question: Does community-based pulmonary rehabilitation 
improve quality of life, respiratory exacerbations, exercise 
performance, and lung function in people with COPD? 
Design: Randomised, controlled trial with concealed 
allocation and blinded outcome assessment. Setting: Two 
hospitals in The Netherlands. Participants: People with 
COPD (GOLD Stages 2 or 3) and impaired exercise capacity 
(< 70% of predicted peak work during incremental cycle 
ergometry). Prior rehabilitation and major co-morbidities 
were exclusion criteria. Randomisation of 199 participants 
allotted 102 to an intervention group and 97 to a control 
group. Interventions: All participants had their medications 
optimised before randomisation. Over 4 months, the 
intervention group visited a local physiotherapist twice a 
week for 30-minute intensive exercise training (endurance 
cycling and walking, upper and lower limb strength/
endurance exercises). They were instructed to do the 
exercises for 30 minutes twice daily at home and to walk 
and cycle outside. They also completed an individualised 
education program using a booklet and, if required, received 
smoking cessation counselling (minimal intervention 
strategy) and 4 visits from a dietitian for counselling and 
supplements. This was followed by a 20-month maintenance 
program, involving monthly visits to the physiotherapist 
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for monitoring and encouragement. After an exacerbation, 
participants were allowed 6 extra training sessions over 
3 weeks. Extra dietitian and nursing appointments were 
made if indicated. The control group participants received 
brief smoking cessation advice and advice to eat more if 
malnourished, from their respiratory physician. Outcome 
measures: The primary outcomes were the St George’s 
Respiratory Questionnaire (SGRQ) total score and the 
number of exacerbations. Secondary outcomes were SGRQ 
domain scores, the modified Medical Research Council 
(MRC) dyspnoea scale, a cycle endurance test, the six-
minute walk test distance (6MWD), strength of respiratory 
and limb muscles, fat-free mass, and lung function. At 
24 months, perceived effectiveness of care was rated on 
a 5-point Likert scale. Results: Follow-up was 93% at 4 
months and 79% at 24 months. At 4 months, improvement 
in SGRQ score was significantly better in the intervention 
group by 4.2 points (95% CI 3.9 to 4.5), but exacerbations 
did not significantly differ, RR 1.01 (95% CI 0.57 to 
1.79). Other outcomes that were significantly better in the 
intervention group were SGRQ activity and impact scores, 
MRC score, cycle endurance time, peak work, 6MWD, 
handgrip force, and fat-free mass. At 24 months, SGRQ, 
cycle endurance time, and 6WMD remained significantly 
better in the intervention group and exacerbations remained 
not significantly different. The intervention was perceived 
as significantly more effective. Conclusion: Community-
based pulmonary rehabilitation is effective for people with 
COPD.
[95% CI calculated by the CAP Co-ordinator using 
unadjusted data.]
Commentary
COPD is the third leading cause of ‘burden of disease’ in 
Australia behind ischaemic heart disease and stroke (Mathers 
et al 1999). Pulmonary rehabilitation has proven efficacy in 
managing people with moderate-to-severe COPD (Ries et 
al 2007). While COPD is usually not diagnosed until it is 
moderately advanced, a survey conducted in France (Roche 
et al 2008) has indicated that even people with mild COPD 
suffer from significant dyspnoea and reduced quality of life. 
Thus, it is appropriate to evaluate the effects of pulmonary 
rehabilitation in people with milder COPD.
The study by van Wetering et al (2009) claims to investigate 
the value of pulmonary rehabilitation in people with ‘less 
advanced’ COPD who have impairment in exercise capacity. 
The study is well designed and believable being a single 
blinded, randomised controlled study with an acceptable 
drop-out rate. However, the eligibility criteria excluded 
people with ‘less advanced’ COPD in terms of lung function. 
The study recruited people with COPD in GOLD stages II 
(FEV1/FVC < 0.7, 50% ≤ FEV1< 80% predicted) and III 
(FEV1/FVC < 0.7, 30% ≤ FEV1 < 50% predicted), which 
equate to moderate and severe COPD. It would have been 
more novel to recruit people with mild COPD (GOLD stage 
I) who have some impairment to exercise capacity.
The study’s short-term results confirm the results of 
previous RCTs, with improvements in quality of life and 
exercise capacity following four months of rehabilitation 
compared to usual care. The results particularly support the 
effectiveness of community rehabilitation programs run by 
physiotherapists. Unfortunately, the results are difficult to 
extrapolate to all clinical environments where rehabilitation 
programs may only have the resources to run for a two-
month period.
Although treatment benefits were still evident as significant 
between-group differences at 24 months, the maintenance 
strategy used was not sufficient to maintain exercise 
capacity and quality of life at the levels seen at the end 
of the 4-month program. Further studies evaluating more 
intensive maintenance programs in the community are 
required.
Zoe McKeough
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